Molecular and phenotypic profiling of sorbitol-fermenting Escherichia coli O157:H− human isolates from Finland  by Eklund, M. et al.
ORIGINAL ARTICLE 10.1111/j.1469-0691.2006.01478.x
Molecular and phenotypic proﬁling of sorbitol-fermenting Escherichia coli
O157:H– human isolates from Finland
M. Eklund1, M. Bielaszewska2, U.-M. Nakari1, H. Karch2 and A. Siitonen1
1Enteric Bacteria Laboratory, Department of Bacterial and Inﬂammatory Diseases, National Public
Health Institute (KTL), Helsinki, Finland and 2Institute of Hygiene and the National Consulting
Laboratory on Hemolytic Uremic Syndrome, University Hospital Mu¨nster, Mu¨nster, Germany
ABSTRACT
This study investigated the occurrence of virulence-associated genes, including stx1, stx2, stx2c, stx2d,
stx2e, eae and its subtypes (a, b, c, ), efa1, cdt-V cluster, enterohaemorrhagic Escherichia coli (EHEC)-hlyA,
katP, espP, etpD, sfpA and the ﬂagellar ﬂiC gene, in nine sorbitol-fermenting (SF), b-glucuronidase-
positive E. coli O157:H– (non-motile) isolates obtained from humans in Finland between 1997 and 2001.
In addition, the production of Shiga toxin (Stx), cytolethal distending toxin (CDT)-V and EHEC
haemolysin (EHEC-Hly) was studied, and the phage type (PT) and pulsed-ﬁeld gel electrophoresis
(PFGE) types were determined. All nine isolates carried eae-c, efa1, EHEC-hlyA, etpD, sfpA and ﬂiC; eight
also harboured the cdt-V gene cluster and ﬁve were positive for stx2. None of the isolates harboured stx1,
stx2c, stx2d, stx2e, katP or espP. All isolates harbouring the corresponding genes also produced Stx2 and
CDT-V in titres ranging from 1:32 to 1:128 and from 1:2 to 1:4, respectively. None of the isolates
expressed EHEC-Hly on enterohaemolysin agar. Seven isolates belonged to PT88 and two had a PT88
variant pattern. Seven isolates showed a close genetic relationship, with a PFGE similarity index (SI) of
92–98%. Two isolates, temporally the ﬁrst and last, obtained 5 years apart, were the most divergent (SI
of 71% and 85%, respectively). The study demonstrated that SF E. coli O157:H– isolates from Finland are
closely related and show a close relationship with SF E. coli O157 strains isolated in Germany. This
ﬁnding suggests a clonality of SF E. coli O157:H– isolates from different geographical regions.
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INTRODUCTION
The most prevalent group of Shiga toxin (Stx)-
producing Escherichia coli (STEC) worldwide are
non-sorbitol-fermenting (NSF), b-glucuronidase-
negative E. coli O157:H7 strains [1]. The NSF
phenotype forms the basis for the identiﬁcation of
these strains on sorbitol MacConkey agar (SMAC)
[2]. However, since 1988, sorbitol-fermenting (SF),
b-glucuronidase-positive E. coli O157:H– (non-
motile) strains have been identiﬁed increasingly
as causative agents in sporadic cases of haemo-
lytic uraemic syndrome (HUS) occurring in
Europe [3,4], as well as in several outbreaks
[2,5,6]. In contrast to STEC O157:H7, strains of SF
STEC O157:H– cannot be distinguished from
normal intestinal ﬂora on SMAC. In Finland, the
ﬁrst b-glucuronidase-positive SF STEC O157:H–
strain was isolated in 1997 [7].
The SF STEC O157:H– strains isolated to date in
Europe share a characteristic combination of
virulence genes, which includes stx2 as the sole
stx gene, eae-c [2] and a complete efa1 (lifA) gene
[8], which encodes a bifunctional protein for
enterohaemorrhagic E. coli (EHEC) adherence
factor (Efa1) [9] and lymphostatin [10]. Most of
these strains also possess a gene cluster (cdt-V)
encoding a novel member of the cytolethal dis-
tending toxin (CDT) family, designated CDT-V
[11], which is uncommon in E. coli O157:H7 [12].
In contrast to NSF E. coli O157:H7 ⁄H–, strains of
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SF E. coli O157:H– lack the tellurite resistance and
adherence-conferring island, which encodes an
adherence-conferring molecule (Iha) and tellurite
resistance [13]. As a consequence, SF E. coli
O157:H– strains do not grow on ceﬁxime–tellurite
SMAC [14], which is used widely in clinical
laboratories for the isolation of tellurite-resistant
NSF E. coli O157:H7 strains [14]. Also, SF STEC
O157:H– strains lack the urease-encoding (ure)
operon that is usually present in E. coli O157:H7
[15]. In addition, a novel mosaic island, absent in
E. coli O157:H7 strains, has been identiﬁed in the
genome of SF STEC O157:H– [16], and SF STEC
O157:H– strains typically harbour plasmid-enco-
ded putative virulence genes, including EHEC-
hlyA, etpD and sfpA, coding for EHEC haemolysin
(EHEC-Hly), a putative type II secretion system
and the major pilin subunit of Sfp ﬁmbriae,
respectively [2,17]. However, the katP and espP
genes, encoding catalase peroxidase (KatP) and
serine protease (EspP), respectively, in E. coli
O157:H7 are absent in SF E. coli O157:H– strains
[2].
The present study investigated the phage type,
genomic DNA macrorestriction pattern, and the
occurrence of a wide range of putative virulence
genes, located on the chromosome or on large
plasmids, in nine SF E. coli O157:H– isolates from
humans in Finland. Expression of the Stx, CDT
and EHEC-Hly proteins was also examined. The
genotypic and phenotypic characteristics of the
Finnish SF STEC O157:H– isolates were compared
with those of a prototype SF STEC O157:H– strain
isolated in Germany.
MATERIALS AND METHODS
Strains and patients
Nine SF E. coli O157:H– isolates from the collection of the
Enteric Bacteria Laboratory, National Public Health Institute,
Helsinki, Finland were investigated. After isolation from stool
cultures of nine different patients between 1997 and 2001, the
isolates were examined for the presence of stx1, stx2 and
eae, and their pulsed-ﬁeld gel electrophoresis (PFGE) type
was determined; the isolates were then stored in sterilised
skimmed-milk tubes at ) 70C. All these tests were repeated
for the present study. Six of the patients lived in different
regions, but three lived in the same geographical area,
although there was no temporal relationship between their
infections (01 ⁄ 1998, 02 ⁄ 1999, 12 ⁄ 1999). None of the patients
had travelled abroad in the 4 weeks preceding their infection.
Two patients suffered from HUS, two patients had bloody
diarrhoea, three had non-bloody diarrhoea, and two were
asymptomatic. The ages of the patients ranged from 1.5 to
48.3 years (mean age 13.1 years; median age 4.7 years). The
methods used originally for isolation from the stool cultures
have been described previously [7,18]. The SF STEC O157:H–
strain 493 ⁄ 89, isolated in Germany [19], and E. coli O157:H7
strain EDL 933, were used for comparisons with the Finnish
SF E. coli O157:H– isolates.
Phenotypic assays
The O:H serotype was determined as described previously
[7,18]. Sorbitol fermentation was detected in the API 20E
system (bioMe´rieux, Marcy l’Etoile, France), on SMAC agar
plates, and in tubes containing sorbitol 0.5% w ⁄v, after
overnight incubation at 37C. Production of b-glucuronidase
was tested using b-glucuronidase diagnostic tablets (A ⁄ S
Rosco, Taastrup, Denmark) according to the manufacturer’s
instructions. Phage typing of the isolates was performed as
described previously [20,21]. Two isolates producing phage
type (PT) reactions that did not conform to the scheme of
standardised phage types were sent to the National Laboratory
for Enteric Pathogens, National Microbiology Laboratory of
the Canadian Science Centre for Human and Animal Health
(Winnipeg, Canada). Production of Stx1 and Stx2 was tested
using a reversed passive latex agglutination assay (VTEC-
RPLA; Denka Seiken, Tokyo, Japan) as described previously
[7]. The activity of EHEC-Hly was assayed on enterohaemo-
lysin agar plates containing deﬁbrinated, washed sheep
erythrocytes 5% v ⁄v and 10 mM CaCl2 [22]. The production
of CDT was tested using Chinese hamster ovary cells as
described previously [11,12]. The CDT titre was deﬁned as the
highest dilution of bacterial supernatant that caused typical
cell distension in 50% of cells after incubation for 5 days
[11,12].
PCR assays
The isolates were examined for the presence of the stx1, stx2,
stx2c, stx2d, stx2e, eae-a, eae-b, eae-c, eae-, efa1, cdt-V, EHEC-
hlyA, etpD, katP, espP and sfpA genes using the PCR primers
and procedures listed in Table 1. The eae gene was detected
and subtyped using a multiplex PCR in which bacterial
suspensions in 500 lL of sterile water were ﬁrst boiled for
10 min and then centrifuged brieﬂy. Aliquots (1.5 lL) of the
supernatants were ampliﬁed in 50-lL reaction mixtures con-
taining 2.5 mM dNTPs, 2.0 mM MgCl2, 200 ng of each primer,
2.5 U of Taq polymerase (Fermentas Life Sciences, Vilnius,
Lithuania) and 1· PCR buffer containing (NH4)2SO4. PCR
ampliﬁcation in a PTC 200 Peltier Thermal Cycler (MJ
Research, Waterstown, MA, USA) comprised 95C for 3 min,
followed by 26 cycles of 94C for 1 min, 54C for 2 min and
72C for 45 s, with a ﬁnal extension at 72C for 10 min. The
ampliﬁed products were separated using electrophoresis in
agarose 1.2% w ⁄v gels and stained with ethidium bromide.
FliC PCR–restriction fragment length polymorphism
(PCR-RFLP) analysis
The ﬂiC gene was ampliﬁed using primers FSa1 and rFSa1
(Table 1) and 15 lL of the PCR product was digested with
HhaI (New England BioLabs, Frankfurt, Germany). Restriction
fragments were separated on agarose 2% w ⁄v gels [28]. The
ﬂiC RFLP patterns of SF E. coli O157:H– isolates were com-
pared with that of E. coli O157:H7 strain EDL933.
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PFGE
Chromosomal DNA of the isolates was investigated by PFGE
according to the PulseNetUSA protocol for E. coli O157:H7
[29,30] using XbaI (New England Biolabs), but omitting the
addition of SDS 20% w ⁄v during preparation of the PFGE
plugs. The clonal similarity index (SI) of the isolates was
calculated using the unweighted pair-group method with
arithmetic average clustering (UPGMA) and BioNumerics
v.3.0 (Applied Maths, Sint-Martens-Latem, Belgium).
RESULTS
Virulence genes of SF E. coli O157:H– strains
Five of the nine SF E. coli O157:H– isolates were
positive for stx2, but contained none of the stx2
variant genes (stx2c, stx2d, stx2e) or stx1 (Table 2).
Four isolates were negative for all stx genes
investigated. All nine isolates carried the eae-c
and efa1 genes, and all but one carried the cdt-V
gene cluster. In addition, all isolates tested posi-
tive for genes encoding EHEC-Hly (EHEC-hlyA),
the putative type II secretion system (etpD) and
Sfp ﬁmbriae (sfpA). However, none of the isolates
harboured katP or espP. The molecular character-
istics of the SF STEC O157:H– isolates from
Finland were identical to those of the prototype
SF STEC O157:H– strain 493 ⁄ 89 from Germany
(Table 2). Moreover, the four stx-negative SF
E. coli O157:H– Finnish isolates possessed all the
non-stx putative virulence genes present in SF
STEC O157:H– isolates (Table 2).
Table 1. PCR primers used in this study
Primer designation Orientation Sequences Target Amplicon size (bp) Referencea
KS7 Forward 5¢-CCC GGA TCC ATG AAA AAA ACA TTA TTA ATA GC-3¢ stx1Bb 285 [3]
KS8 Reverse 5¢-CCC GAA TTC AGC TAT TCT GAG TCA ACG-3¢
GK3
GK4
Forward
Reverse
5¢-ATG AAG AAG ATG TTT ATG-3¢
5¢-TCA GTC ATT ATT AAA CTG-3¢
stx2B,
stx2cBc
260 [3]
LP43 Forward 5¢-ATC CTA TTC CCG GGA GTT TAC G-3¢ stx2A 584 [3]
LP44 Reverse 5¢-GCG TCA TCG TAT ACA CAG GAG C-3¢ and variantsd
VT2-cm Forward 5¢-AAG AAG ATA TTT GTA GCG G-3¢ stx2dB 256 [3]
VT2-f Reverse 5¢-TAA ACT GCA CTT CAG CAA AT-3¢
FK1 Forward 5¢-CCC GGA TCC AAG AAG ATG TTT ATA G-3¢ stx2eB 280 [3]
FK2 Reverse 5¢-CCC GAA TTC TCA GTT AAA CTT CAC C-3¢
EaeP1 Forward 5¢-CTG AAC GGC GAT TAC GCG AA-3¢ eaee 360 [23]
SK2 Reverse 5¢-CCC GGA TCC GTC TCG CCA GTA TTC G-3¢ [19]
EaeF2 Forward 5¢-CTG GAT CGT ATC GTC TGG-3¢ eaef This study
Ecoeaea Reverse 5¢-CTG GAG TTG TCG ATG TT-3¢ eae-a 739 [23]
Ecoeaeb Reverse 5¢-GTA ATT GTG GCA CTC C-3¢ eae-b 1022 [23]
Ecoeaec Reverse 5¢-GCC TCT GAC ATT GTT AC-3¢ eae-c 870 [23]
LP5 Reverse 5¢-AGC TCA CTC GTA GAT GAC GGC AAG CG-3¢ eae- 1189 [24]
E643f Forward 5¢-TAT CAG GCC AAT CAA AAC AG-3¢ efa1g 974 [8]
E1598r Reverse 5¢-AGA CAC TGG TAA ATT TCG C-3¢
E5242f Forward 5¢-TAA GCG AGC CCT GAT AAG CA-3¢ efa2g 630 [8]
E5854r Reverse 5¢-CGT GTT GCT TGC CTT TGC-3¢
E7044f Forward 5¢-TGT CTA ACT GGA TTG TAT GGC-3¢ efa3g 685 [8]
E7710r Reverse 5¢-ATG TTG TTC CCG GCC CAG T-3¢
c338f Forward 5¢-AGC ATT AAA TAA AAG CAC GA-3¢ cdt-VAh 1329 [12]
c2135r Reverse 5¢-TAC TTG CTG TGG TCT GCT AT-3¢
c1309f Forward 5¢-AGC ACC CGC AGT ATC TTT GA-3¢ cdt-VBh 1363 [12]
c2166r Reverse 5¢-AGC CTC TTT TAT CGT CTG GA-3¢
P105 Forward 5¢-GTC AAC GAA CAT TAG ATT AT-3¢ cdt-VCh 748 [12]
c2767r Reverse 5¢-ATG GTC ATG CTT TGT TAT AT-3¢
HlyA1 Forward 5¢-GGT GCA GCA GAA AAA GTT GTA G-3¢ EHEC-hlyA 1550 [25]
HlyA4 Reverse 5¢-TCT CGC CTG ATA GTG TTT GGT A-3¢
D1 Forward 5¢-CGT CAG GAG GAT GTT CAG-3¢ etpD 1062 [26]
D13R Reverse 5¢-CGA CTG CAC CTG TTC CTG ATT A-3¢
wkat-B Forward 5¢-CTT CCT GTT CTG ATT CTT CTG G-3¢ katP 2125 [27]
wkat-F Reverse 5¢-AAC TTA TTT CTC GCA TCA TCC-3¢
esp-A Forward 5¢-AAA CAG CAG GCA CTT GAA CG-3¢ espP 1830 [26]
esp-B Reverse 5¢-GGA GTC GTC AGT CAG TAG AT-3¢
sfpA-U Forward 5¢-AGC CAA GGC CAA GGG ATT ATT A-3¢ sfpA 440 [17]
sfpA-L Reverse 5¢-TTA GCA ACA GCA GTG AAG TCT C-3¢
FSa1 Forward 5¢-CAA GTC ATT AAT AC(A ⁄C) AAC AGC C-3¢ ﬂiC 1600 [28]
rFSa1 Reverse 5¢-GAC AT(A ⁄G) TT(A ⁄G) GA(G ⁄A ⁄C) ACT TC(G ⁄C) GT-3¢
aPCR conditions were those described in the references.
bPrimers targeting the B subunit of stx1.
cstx2 and stx2c were distinguished by restriction analysis with HaeIII [3].
dPrimers targeting the A subunit of stx2, stx2c, stx2d and stx2e.
eUniversal primers targeting the eae gene.
fAllele-speciﬁc primers targeting the subtypes of the eae gene. Primer EaeF2 is complementary to reverse primer EaeP2 [23].
gThree different regions of efa1 (c. 10 kb long) were targeted by the three PCRs.
hcdt-VA, cdt-VB and cdt-VC are three genes encoding the CDT-V.
EHEC, enterohaemorrhagic Escherichia coli.
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RFLP patterns of ﬂiC gene
The ﬂiC RFLP pattern for each of the nine SF
E. coli O157:H– isolates from Finland was identi-
cal to that of E. coli O157:H7 strain EDL933 (data
not shown).
Phenotypic characteristics
All nine E. coliO157:H– isolates fermented sorbitol
after overnight incubation and produced b-glucu-
ronidase. Seven isolates belonged to PT88 and two
were variants of PT88 (PT88 var.) (Table 2). All
ﬁve isolates that possessed the stx2 gene produced
Stx2 in the latex agglutination assay, with titres
ranging from 1:32 to 1:128. Also, all eight isolates
that harboured the cdt-V gene cluster produced
biologically active CDT, as demonstrated by the
ability of the culture supernatants to cause pro-
gressive distension in Chinese hamster ovary cells;
however, the CDT titres were low (1:2 to 1:4)
(Table 2). Although all nine SF E. coli O157:H–
isolates contained the EHEC-hlyA gene, they
did not show the EHEC-Hly phenotype when
cultured overnight on enterohaemolysin agar
(Table 2). With the exception of phage type, the
phenotypes of the SF E. coli O157:H– isolates
obtained from Finland were identical to that of
the German strain 493 ⁄ 89 (Table 2).
DNA macrorestriction proﬁles
The PFGE banding patterns of the nine SF E. coli
O157:H– isolates varied by one to 14 bands, with
three distinct clusters identiﬁed (groups 1, 2 and
3) (Fig. 1). Seven isolates belonged to group 1,
Table 2. Phenotypic and genotypic characteristics of sorbitol-fermenting (SF) Escherichia coli O157:H– human isolates
obtained in Finland, compared with those of the prototype SF Shiga toxin-producing E. coli (STEC) O157:H– strain 493 ⁄ 89
from Germany
Strain Serotype
Presence or absence of chromosomal or plasmid genesa
Chromosomal genes Plasmid genes Phenotypic characteristics
ﬂiC-RFLP
patternb stx eae efa1c cdt-Vd EHEC-hylA etpD katP espP sfpA Stx2 titre CDT titre EHEC-Hlye Phage type
IH 53440 O157:H– H7 stx2 c + – + + – – + 1:128 – – 88 var.
IH 56909 O157:H– H7 stx2 c + + + + – – + 1:64 1:2 – 88
IH 56969 O157:H– H7 stx2 c + + + + – – + 1:64 1:4 – 88
IH 57086 O157:H– H7 stx2 c + + + + – – + 1:64 1:4 – 88
IH 57201 O157:H– H7 stx2 c + + + + – – + 1:32 1:2 – 88
IH 56776 O157:H–f H7 –g c + + + + – – + –g 1:4 – 88
IH 56905 O157:H–f H7 – c + + + + – – + – 1:2 – 88
IH 57075 O157:H– H7 – c + + + + – – + – 1:2 – 88
IH 57084 O157:H– H7 – c + + + + – – + – 1:2 – 88 var.
493 ⁄ 89 O157:H– H7 stx2 c + + + + – – + 1:32 1:4 – 23
aGenes encode the following putative virulence factors: stx, Shiga toxin (Stx); eae, intimin; efa1, enterohaemorrhagic E. coli (EHEC) factor for adherence; cdt-V, cytolethal
distending toxin (CDT)-V; EHEC-hlyA, EHEC haemolysin; etpD, putative type II secretion system; katP, catalase peroxidase; espP, serine protease; sfpA, plasmid-encoded
ﬁmbriae of SF STEC O157:H– (Sfp).
bThe ﬂiC-RFLP patterns of SF E. coli O157:H– strains were identical to that of E. coli O157:H7 strain EDL933.
c+, all PCRs for the three different efa1 regions (Table 1) were positive, which indicates the presence of a complete efa1 gene (c. 10 kb long)..
d+, all PCRs for cdt-VA, cdt-VB and cdt-VC (Table 1) were positive, which indicates the presence of the complete cdt-V cluster; –, all PCRs for the respective cdt-V genes were
negative.
e–, no haemolysis.
fIsolates IH 56776 [31,32] and IH 56905 (unpublished data) were previously motile and of ﬂagellar type H7.
gStrain IH 56776 had previously been shown to harbour stx2 and produced Stx2 with a titre of 1:128 [31].
RFLP, restriction fragment length polymorphism.
Dice (Tol 1.0%-1.0%) (H>0.0% S>0.0%) [0.0%-100.0%]
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PFGE profile Isolate
No. 
Serotype Phage
type
PFGE
type
stx
carriage
Month / year
of isolation 
IH 57075    O157:H¯      88 A -   11 / 1999
IH 57084    O157:H¯      88 var. B -   12 / 1999
IH 56969    O157:H¯      88            C  2          4 / 1999
IH 57086   O157:H¯      88 D  2      12 / 1999
IH 56776    O157:H¯      88 E -     1 / 1998
IH 56905   O157:H¯      88 F -     2 / 1999
IH 56909    O157:H¯      88 G  2            3 / 1999
IH 57201    O157:H¯      88 H  2            8 / 2001
IH 53440    O157:H¯      88 var.        I  2            7 / 1997
 1
2
3
Fig. 1. Cluster analysis of the sorbitol-fermenting Escherichia coli O157:H– isolates from Finland following pulsed-ﬁeld gel
analysis of XbaI-digested chromosomal DNA.
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with an SI of 92–98% and band differences of one
(PFGE types A and B, A and C, F and G) to seven
(PFGE types B and E, C and E) bands. The largest
difference between subtypes in terms of numbers
of bands (i.e., 14 bands) was in groups 2 and 3 for
subtypes H (IH 57201) and I (IH 53440), where H
(IH 57201) was the last of the nine SF E. coli
O157:H– strains isolated in Finland and I
(IH 53440) was the ﬁrst (Fig. 1).
DISCUSSION
During the past decade, nearly 130 human infec-
tions caused by STEC O157 have been identiﬁed
in Finland [7,32] (M. Eklund, S. Waarala, T.
Heiskanen, A. Siitonen, unpublished results). Of
these, 10% were caused by non-motile STEC
O157:H– strains, of which 75% fermented sorbitol
(M. Eklund, S. Waarala, T. Heiskanen, A. Siitonen,
unpublished results). In a few cases, the NSF
STEC O157:H7 strains could be traced to cattle or
cattle products [33]. In contrast, the source of all
human infections involving SF E. coli O157:H– has
remained unknown.
Internationally standardised phage typing,
subtyping of stx and eae genes, and molecular
ﬁngerprinting using PFGE have proved to be
valuable tools in tracing the source of an
infection and in studying epidemiological rela-
tionships among E. coli O157 strains [34]. In the
present study, these techniques were used to
examine nine SF b-glucuronidase-positive E. coli
O157:H– human isolates from Finland. All of
these isolates shared non-stx putative virulence
genes, including eae-c, efa1 and plasmid genes
etpD, EHEC-hlyA and sfpA, and most of them
also harboured the cdt-V cluster. The presence
of sfpA in all the Finnish isolates is a partic-
ularly important ﬁnding, since this gene has
been reported to be a marker for SF E. coli
O157:H– isolates [17], and has been proposed as
a useful diagnostic target for identiﬁcation of
SF STEC O157 isolates in the stools of patients
[17]. Moreover, as was the case with isolates
from the German clone [2], the ﬁve SF STEC
O157:H– isolates from Finland harboured stx2 as
the sole stx gene. The stx2 genes were expressed
in all isolates, as demonstrated by the reversed
passive latex agglutination assay, with Stx2
titres ranging from 1:32 to 1:128. This is in
contrast to some stx2 variant-containing STEC
strains, which secrete no detectable Stx in vitro,
although they possess structurally intact stx
genes [35].
Like the SF E. coli O157:H– isolates from other
countries [2,5,36,37], the isolates from Finland
failed to express EHEC-Hly, as demonstrated by
the absence of an enterohaemolytic phenotype on
enterohaemolysin agar. Most of the isolates from
Finland belonged to PT88, which is also the most
frequent phage type identiﬁed in SF STECO157:H–
strains in Germany [38]. In contrast, PT23, which
has occurred occasionally among SF STEC
O157:H– strains isolated in Germany [38], was
not found among the O157 isolates from Finland.
In the present study, stx genes were absent
from four SF E. coli O157:H– isolates. However,
since one of these (IH 56776) had been shown
previously to carry the stx2 gene [31], it was
concluded that the gene was lost during labora-
tory storage or following subculture. E. coli
O157:H7 ⁄H– strains lacking stx genes have been
associated with human disease [39], and this has
led to the suggestion that such strains possess as
yet unknown non-Stx virulence traits capable of
causing severe symptoms in susceptible patients
[2,39]. In this context, the ﬁnding of CDT-V in
eight of nine SF E. coli O157:H– isolates from
Finland, including all four stx-negative isolates, is
of particular interest. CDT-V has been shown to
cause irreversible damage to human endothelial
cells, which are the major targets in HUS [40].
Moreover, STEC bacteria have multiple type III
secretion systems, which are required for the
process of ﬂagellar assembly and the functionality
of the locus of the enterocyte effacement patho-
genicity island that mediates the introduction of
virulence factors into mammalian cells [41].
Because these systems can interfere with each
other, it has been suggested that an absence of
ﬂagellar events among non-motile strains might
confer an advantage in the expression of other
virulence factors [41].
Interestingly, two isolates (IH 56777 and
IH 56905), which had previously been motile
and shown to produce the H7 ﬂagellar antigen
[32], were non-motile when retested in the present
study. Although motility is not expressed in SF
E. coli O157:H– bacteria, strains typically possess
the chromosomal ﬂiC locus for the H7 antigen.
This was the case for each of the nine isolates
investigated in this study, demonstrating that all
belonged to the H7 clonal complex. In SF E. coli
O157:H– strains of German origin, it has been
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shown that a 12-bp deletion in the master control
operon of ﬂagellum biosynthesis (ﬂhC) results in
the non-motile phenotype [41].
In clonal analyses, SF E. coli O157:H– strains
isolated in Germany displayed distinct genetic
proﬁles, indicating that they belong to a clonal
group different to that of E. coli O157:H7
[19,41,42]. In the present study, PFGE analysis
demonstrated that seven of the nine isolates
clustered together (SI 92–98%). According to the
results of long-term epidemiological surveillance,
isolates that differ by four bands or less, or that
have an SI of > 94% in PFGE banding patterns, are
considered to be related if other genotypic and
phenotypic markers support this conclusion
[38,43,44]; these criteria were met for these seven
isolates. The two remaining isolates were the ﬁrst
and last to be isolated, in 1997 (IH 53440; subtype
I) and 2001 (IH 57201; subtype H), with SIs of
71% and 85%, respectively. No changes in the
characteristics of these and the other isolates were
detected following storage at ) 70C. Since there
was no apparent epidemiological link between
the patients, it was concluded that the isolates
belong to different lineages. This is in accord with
other studies, where similarities of > 75–80% have
been used to signify a genetic relationship in a
PFGE dendrogram [34,36,45].
Human infections involving SF STEC O157:H–
were linked to cattle for the ﬁrst time during the
late 1990s [36], and a report from Austria has
described the isolation of SF STEC O157:H–
strains possessing stx2 and eae from a child with
HUS who had consumed unpasteurised cow’s
milk [46]. In Germany, epidemiological investiga-
tions of a major outbreak of HUS caused by SF
STEC O157:H– showed an association with the
consumption of beef sausages [5]. In Finland,
O157:H– isolates accounted for 5–6% of STEC
O157 isolates from cattle [47], but data concerning
the sorbitol-fermentation properties of these iso-
lates are unfortunately lacking. There are also
reports of SF E. coli O157:H– isolates from cattle
on a farm associated with a human NSF E. coli
O157:H7 infection [33].
The SF non-motile serogroup O157 has
emerged as a cause of human disease in a
growing number of countries, including Finland.
SF STEC O157:H– is the second most common
cause of HUS in Germany [3,4], but organisms
belonging to this group have also been isolated in
the Czech Republic [37], Austria [4,48] and the UK
[49]. Isolation of SF E. coli O157:H– for the ﬁrst
time outside Europe was reported recently in
Australia [50]. The spread of these new pathogens
in Europe, and beyond, demonstrates clearly the
need for appropriate procedures for their micro-
biological diagnosis, based on their characteristic
phenotypic and genotypic features. The combined
detection of O serogroup, sorbitol fermentation,
phage type, eae type, Stx production and carriage
of stx2, as well as the carriage of genes typical for
SF E. coli O157:H–, such as sfpA [17], may be
useful for the identiﬁcation of these pathogens in
stool samples and in tracing sources of infection
across national and international boundaries.
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